305 related articles for article (PubMed ID: 16735866)
1. Uncertain efficacy of daptomycin for prosthetic joint infections: a prospective case series.
Rao N; Regalla DM
Clin Orthop Relat Res; 2006 Oct; 451():34-7. PubMed ID: 16735866
[TBL] [Abstract][Full Text] [Related]
2. Methicillin-resistant Staphylococcus aureus prosthetic aortic valve endocarditis with paravalvular abscess treated with daptomycin.
Mohan SS; McDermott BP; Cunha BA
Heart Lung; 2005; 34(1):69-71. PubMed ID: 15647736
[TBL] [Abstract][Full Text] [Related]
3. Guiding empirical antibiotic therapy in orthopaedics: The microbiology of prosthetic joint infection managed by debridement, irrigation and prosthesis retention.
Moran E; Masters S; Berendt AR; McLardy-Smith P; Byren I; Atkins BL
J Infect; 2007 Jul; 55(1):1-7. PubMed ID: 17343916
[TBL] [Abstract][Full Text] [Related]
4. [Linezolid in the treatment of antibiotic-resistant gram-positive infections of the musculoskeletal system].
Jahoda D; Nyc O; Pokorný D; Landor I; Sosna A
Acta Chir Orthop Traumatol Cech; 2006 Oct; 73(5):329-33. PubMed ID: 17140514
[TBL] [Abstract][Full Text] [Related]
5. Conservative treatment of staphylococcal prosthetic joint infections in elderly patients.
Barberán J; Aguilar L; Carroquino G; Giménez MJ; Sánchez B; Martínez D; Prieto J
Am J Med; 2006 Nov; 119(11):993.e7-10. PubMed ID: 17071171
[TBL] [Abstract][Full Text] [Related]
6. Daptomycin therapy for invasive Gram-positive bacterial infections in children.
Ardura MI; Mejías A; Katz KS; Revell P; McCracken GH; Sánchez PJ
Pediatr Infect Dis J; 2007 Dec; 26(12):1128-32. PubMed ID: 18043450
[TBL] [Abstract][Full Text] [Related]
7. High-dose daptomycin for cardiac implantable electronic device-related infective endocarditis.
Durante-Mangoni E; Casillo R; Bernardo M; Caianiello C; Mattucci I; Pinto D; Agrusta F; Caprioli R; Albisinni R; Ragone E; Utili R
Clin Infect Dis; 2012 Feb; 54(3):347-54. PubMed ID: 22100575
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of daptomycin in complicated skin and skin-structure infections due to methicillin-sensitive and -resistant Staphylococcus aureus: results from the CORE Registry.
Martone WJ; Lamp KC
Curr Med Res Opin; 2006 Dec; 22(12):2337-43. PubMed ID: 17257448
[TBL] [Abstract][Full Text] [Related]
9. Safety and clinical outcomes when utilizing high-dose (> or =8 mg/kg) daptomycin therapy.
Moise PA; Hershberger E; Amodio-Groton MI; Lamp KC
Ann Pharmacother; 2009 Jul; 43(7):1211-9. PubMed ID: 19584384
[TBL] [Abstract][Full Text] [Related]
10. Daptomycin for the treatment of gram-positive bacteremia and infective endocarditis: a retrospective case series of 31 patients.
Segreti JA; Crank CW; Finney MS
Pharmacotherapy; 2006 Mar; 26(3):347-52. PubMed ID: 16503714
[TBL] [Abstract][Full Text] [Related]
11. Use of antibiotic-loaded polymethylmethacrylate beads for the treatment of extracavitary prosthetic vascular graft infections.
Stone PA; Armstrong PA; Bandyk DF; Brumberg RS; Flaherty SK; Back MR; Johnson BL; Shames ML
J Vasc Surg; 2006 Oct; 44(4):757-61. PubMed ID: 17012000
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of linezolid for Gram-positive orthopedic infections: a prospective case series.
Rao N; Hamilton CW
Diagn Microbiol Infect Dis; 2007 Oct; 59(2):173-9. PubMed ID: 17574788
[TBL] [Abstract][Full Text] [Related]
13. Regional antibiotic delivery for the treatment of experimental prosthetic graft infections.
Keeling WB; Myers AR; Stone PA; Heller L; Widen R; Back MR; Johnson BL; Bandyk DF; Shames ML
J Surg Res; 2009 Dec; 157(2):223-6. PubMed ID: 19560786
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with daptomycin for the treatment of patients with knee and hip periprosthetic joint infections.
Corona Pérez-Cardona PS; Barro Ojeda V; Rodriguez Pardo D; Pigrau Serrallach C; Guerra Farfán E; Amat Mateu C; Flores Sanchez X
J Antimicrob Chemother; 2012 Jul; 67(7):1749-54. PubMed ID: 22511636
[TBL] [Abstract][Full Text] [Related]
15. Outcomes with daptomycin versus standard therapy for osteoarticular infections associated with Staphylococcus aureus bacteraemia.
Lalani T; Boucher HW; Cosgrove SE; Fowler VG; Kanafani ZA; Vigliani GA; Campion M; Abrutyn E; Levine DP; Price CS; Rehm SJ; Corey GR; Karchmer AW;
J Antimicrob Chemother; 2008 Jan; 61(1):177-82. PubMed ID: 17999973
[TBL] [Abstract][Full Text] [Related]
16. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
Rybak MJ
Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
[TBL] [Abstract][Full Text] [Related]
17. A pilot study of high-dose short duration daptomycin for the treatment of patients with complicated skin and skin structure infections caused by gram-positive bacteria.
Katz DE; Lindfield KC; Steenbergen JN; Benziger DP; Blackerby KJ; Knapp AG; Martone WJ
Int J Clin Pract; 2008 Sep; 62(9):1455-64. PubMed ID: 18662172
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and safety of daptomycin in the treatment of Gram-positive catheter-related bloodstream infections in cancer patients.
Chaftari AM; Hachem R; Mulanovich V; Chemaly RF; Adachi J; Jacobson K; Jiang Y; Raad I
Int J Antimicrob Agents; 2010 Aug; 36(2):182-6. PubMed ID: 20452752
[TBL] [Abstract][Full Text] [Related]
19. Bactericidal agents in the treatment of MRSA infections--the potential role of daptomycin.
French GL
J Antimicrob Chemother; 2006 Dec; 58(6):1107-17. PubMed ID: 17040922
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of daptomycin and tigecycline against coagulase-negative staphylococcus blood isolates from bone marrow transplant recipients.
Kratzer C; Rabitsch W; Hirschl AM; Graninger W; Presterl E
Eur J Haematol; 2007 Nov; 79(5):405-9. PubMed ID: 17714506
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
